Onkolytische Viren zur Verstärkung der PD‐1‐Hemmung bei metastasierendem kutanem Plattenepithelkarzinom-Reference-Cited by-同舟云学术

Onkolytische Viren zur Verstärkung der PD‐1‐Hemmung bei metastasierendem kutanem Plattenepithelkarzinom

Published:2024-07 Issue:7 Volume:22 Page:1016-1019
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:J Deutsche Derma Gesell

Author:

Pham James P.¹²,Zdanska Oksana¹,Selga Mariz¹,Javier Janelle¹,O'Grady Aaron¹,Chin Venessa¹²,Forstner Dion²³,Hsu Eugene²⁴,Liu Jia¹²⁵

Affiliation:

1. Department of Medical Oncology The Kinghorn Cancer Centre St Vincent's Hospital Sydney Darlinghurst NSW Australia

2. School of Clinical Medicine UNSW Medicine and Health St Vincent's Clinical Campus Darlinghurst NSW Australia

3. GenesisCare Radiation Oncology St Vincent's Clinic Darlinghurst NSW Australia

4. Department of Radiology St Vincent's Hospital Sydney Darlinghurst NSW Australia

5. Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.15423_g

Reference10 articles.

1. Cutaneous squamous cell carcinoma: state of the art, perspectives and unmet needs;Heppt MV;J Dtsch Dermatol Ges,2023

2. Oncolytic viruses: a new class of immunotherapy drugs

3. Abstract 3275: Combination of talimogene laherparepvec (T‐VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD‐1 inhibitor: SWOG S1607;Hu‐Lieskovan S;Clin Cancer Res,2023

4. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

5. Reovirus as an Oncolytic Agent Against Experimental Human Malignant Gliomas